NCT02191137 Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION) Status COMPLETED Phase PHASE4
NCT02185560 Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02180828 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Status COMPLETED Phase PHASE4
NCT02175654 Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab Status TERMINATED Phase PHASE2
NCT02170038 Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol Status COMPLETED Phase PHASE1
NCT02170025 Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients Status TERMINATED Phase PHASE2
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial Status COMPLETED Phase PHASE4
NCT02168777 Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer Status TERMINATED Phase PHASE1
NCT02164240 Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST Status COMPLETED Phase PHASE1
NCT02161419 RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT02161081 A Study on Improved Dynamic Myocardial Perfusion With Less Effective Radiation Dose in CT (SIMPLE CT) Status COMPLETED Phase NA
NCT02159326 Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women Status COMPLETED Phase PHASE1
NCT02159261 Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles Status COMPLETED Phase N/A
NCT02157077 Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration Status COMPLETED Phase PHASE3
NCT02156401 VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE Status RECRUITING Phase N/A
NCT02155491 Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events Status COMPLETED Phase N/A